MAPT and early-onset autosomal dominant Alzheimer disease: Total tau (T-tau) and p-tau181 levels in the CSF can both predict the outcomes of individuals with motor cognitive impairment as well as determine the severity of neuronal degeneration in progressive Alzheimer's disease [53, 60].